Results indicate that re-TURB improves risk assessment for high-grade T1 bladder cancer, suggesting new treatment strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fernández-Mardomingo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: